{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:47:40Z","timestamp":1785833260823,"version":"3.56.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>\n                    Warthin tumor is the second most common benign parotid neoplasm and often shows marked uptake on\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT, frequently mimicking malignancy. In contrast, its imaging characteristics on fibroblast activation protein (FAP)\u2013targeted PET\/CT remain insufficiently defined. We report 2 cases of parotid Warthin tumors that demonstrated marked FDG uptake but absent or minimal uptake on FAP-targeted PET\/CT using\n                    <jats:sup>68<\/jats:sup>\n                    Ga-FAPI-04 and\n                    <jats:sup>68<\/jats:sup>\n                    Ga-FAP-2286. This discordant imaging pattern suggests that FAP-targeted PET\/CT may aid in distinguishing Warthin tumor from malignant lesions.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006392","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:01:07Z","timestamp":1772031667000},"page":"591-593","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Comparative 18F-FDG PET\/CT and FAP-targeted PET\/CT Findings in Parotid Warthin Tumor"],"prefix":"10.1097","volume":"51","author":[{"given":"Ke","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Theranostics Key Laboratory of Sichuan Province"},{"name":"Institute of Nuclear Medicine, Southwest Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Theranostics Key Laboratory of Sichuan Province"},{"name":"Institute of Nuclear Medicine, Southwest Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Theranostics Key Laboratory of Sichuan Province"},{"name":"Institute of Nuclear Medicine, Southwest Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Southwest Medical University, Luzhou, Sichuan, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4088-7649","authenticated-orcid":false,"given":"Yue","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Theranostics Key Laboratory of Sichuan Province"},{"name":"Institute of Nuclear Medicine, Southwest Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12105-023-01559-5","article-title":"Warthin Tumor of the parotid gland: the history of an eponym","volume":"17","author":"Ide","year":"2023","journal-title":"Head Neck Pathol"},{"key":"R2-20260605","first-page":"148","article-title":"Cytomorphological findings in diagnosis of Warthin tumor","volume":"50","author":"Koybasioglu","year":"2020","journal-title":"Turk J Med Sci"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/hed.27099","article-title":"Cytologic diagnosis of parotid gland Warthin tumor: systematic review and meta-analysis","volume":"44","author":"Fisher","year":"2022","journal-title":"Head Neck"},{"key":"R4-20260605","first-page":"1256","article-title":"Warthin tumor of the parotid gland: diagnostic value of MR imaging with histopathologic correlation","volume":"25","author":"Ikeda","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"key":"R5-20260605","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1097\/RLU.0000000000003291","article-title":"Warthin Tumor incidentally detected on PET\/CT showing both 68Ga-DOTANOC and 18F-FDG uptake","volume":"46","author":"Vaz","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/RLU.0b013e318238f244","article-title":"Bilateral and multifocal Warthin\u2019s tumors of parotid glands: PET\/CT imaging","volume":"37","author":"Nguyen","year":"2012","journal-title":"Clin Nucl Med"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12149-010-0394-6","article-title":"Efficacy of conventional whole-body 18F-FDG PET\/CT in the incidental findings of parotid masses","volume":"24","author":"Wang","year":"2010","journal-title":"Ann Nucl Med"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2967\/jnumed.123.265530","article-title":"Fibroblast activation protein and glycolysis in lymphoma diagnosis: comparison of 68Ga-FAPI PET\/CT and 18F-FDG PET\/CT","volume":"64","author":"Chen","year":"2023","journal-title":"J Nucl Med"},{"key":"R9-20260605","first-page":"1821","article-title":"Head-to-head comparison of FDG and radiolabeled FAPI PET: a systematic review of the literature","volume":"13","author":"Guglielmo","year":"2023","journal-title":"Life (Basel)"},{"key":"R10-20260605","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.7150\/thno.69475","article-title":"Fibroblast activation protein-based theranostics in cancer research: a state-of-the-art review","volume":"12","author":"Zhao","year":"2022","journal-title":"Theranostics"},{"key":"R11-20260605","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00259-021-05522-w","article-title":"The potential utility of [68Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent-comparison with [18F]FDG","volume":"49","author":"Lan","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T20:00:29Z","timestamp":1780689629000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006392","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"2025-12-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}